Catalyst Wire Dossier Catalyst Wire Dossier
EMA safety_alert · 2021-07-22

COVID-19 Vaccine Janssen: Guillain-Barré syndrome listed as a very rare side effect

View source ↗

Summary

EU authorities list Guillain-Barré syndrome as a very rare side effect of the Janssen COVID-19 vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • COVID-19 Vaccine Janssen (Ad26.COV2.S)